49559-83-3 Usage
General Description
5-Methoxy-3H-benzooxazole-2-thione is a chemical compound with the molecular formula C9H7NOS. It is a heterocyclic organic compound containing a benzooxazole ring with a methoxy group attached at the 5-position and a thione functional group at the 2-position. 5-methoxy-3H-benzooxazole-2-thione has potential pharmaceutical and industrial applications due to its unique chemical structure and properties. 5-Methoxy-3H-benzooxazole-2-thione has been studied as a potential antimicrobial and antifungal agent, and it also has potential as a building block in the synthesis of other organic compounds. Additionally, it has been investigated for its potential use in the development of materials with specific electronic or optical properties. Overall, 5-Methoxy-3H-benzooxazole-2-thione is a versatile chemical with a range of potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 49559-83-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,9,5,5 and 9 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 49559-83:
(7*4)+(6*9)+(5*5)+(4*5)+(3*9)+(2*8)+(1*3)=173
173 % 10 = 3
So 49559-83-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H7NO2S/c1-10-5-2-3-7-6(4-5)9-8(12)11-7/h2-4H,1H3,(H,9,12)
49559-83-3Relevant articles and documents
OCTAHYDROPYRROLO [3, 4-c] PYRROLE DERIVATIVES AND USES THEREOF
-
Paragraph 00186; 00204, (2017/07/04)
The invention relates to octahydropyrrolo [3, 4-c] pyrrole derivatives and uses thereof. Compounds and pharmaceutical compositions comprising the compounds provided herein are used for antagonizing orexin receptors. The invention also relates to processes for preparing the compounds and pharmaceutical compositions, and uses thereof in treating or preventing a disease related to orexin receptors.
CYANOISOQUINOLINE COMPOUNDS AND METHODS OF USE THEREOF
-
Page/Page column 86, (2008/06/13)
The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure: Formula (I).
NOVEL PIPERAZINES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
-
Page/Page column 79, (2008/06/13)
Disclosed are novel piperazine derivatives that act as agonists of the α7 nAChR. Also disclosed are phannaceutical compositions, methods of treating inflammatory conditions, methods of treating CNS disorders, methods for inhibiting cytokine release from mammalian cells and methods for the preparation of the novel compounds.